Social Media Ideas for Tlry

Tilray Brands climbs 8%, extending prior day's gains

Trulieve Cannabis: First NYSE-Listed Cannabis Stock Is A Buy

Tilray Brands Expects to Hit a Major Milestone for the Current Fiscal Year: $1 Billion in Annual Revenue. Here's How it...

The cannabis stock has struggled despite Tilray achieving solid growth in its most recent fiscal year.

Tilray Brands Looks Ready For Another Large Short Squeeze Move

Tilray's Rescheduling Rally Keeps Fading -- Where Will the Stock Be if Washington Stalls Again?

Don't expect a rebound anytime soon.

Tyra Biosciences: 'Hold' IR-NMIBC Data September 9th 2026, With Caution Ahead For 2027 Readouts

TriSalus Life Sciences, Inc. (TLSI) Q2 2026 Earnings Call Transcript

TribeTokes Named to the 2026 Inc. 5000 List of America's Fastest-Growing Private Companies

TribeTokes ranks No. 2,888 with 108 percent three-year revenue growth, and is the only New York City cannabis company on this year's list NEW YORK, Aug. 24, 2026 /PRNewswire-PRWeb/...

Tyra Biosciences: SURF302 Is A Worthwhile Binary Bet

TG Therapeutics: Briumvi's Growth Attracts Buyout Rumors

Liquidia: YUTREPIA's Launch Opens Upside If Growth Remains And Margins Follow

Tenet (THC) Q2 2026 Earnings Call Transcript

Higher-acuity shift drives guidance hikes across revenue and cash flow.

Pain drugmaker Latigo outlines plans to go public

The Westlake-founded company specializes in non-opioid drugs that target sodium ion channels, and is now adding to what’s already been a busy month for the biotech IPO queue.

BioXcel files for Chapter 11, will sell assets to Teva

Lyntris files for IPO, plans to list on NYSE under "LYNX"

Tourmaline Oil Corp. 2026 Q2 - Results - Earnings Call Presentation

TerrAscend Corp. (TSND:CA) Q2 2026 Earnings Call Transcript

Sell Recreational Cannabis as "Medicine"- Federal Class Action Alleges a "Concerted Campaign"

The federal governments policy contradiction is unavoidable:The federal government is conferring the legitimacy and financial benefits of Schedule III medicine on state-licensed op...

Rescheduling Marijuana: The Bet That May Be About To Go Very Wrong

"After Years of Warning Investors That Their Business Violated Federal Law, America's Largest Cannabis Companies Are Now Betting Everything on One Attorney General's Order Survivin...

AtaiBeckley: 'Hold'; Eli Lilly Acquisition For $2.8 Billion Adds To Its Neuroscience Pipeline

A Look Into the ALJ's Crystal Ball: What the DEA Marijuana Hearing Record May Be Telling Us

With post hearing briefs due August 17 and Administrative Law Judge Derek C. Julius expected to issue a recommendation thereafter, Duane Boise CEO MMJ International Holdings says "...

Traeger outlines $435M-$465M 2026 revenue outlook while planning nationwide Lowe's launch in spring 2027

The Cannabis Industry Built on Schedule III. Federal Courts Are About to Decide Whether That Foundation Holds

"As cannabis companies pursue anticipated tax savings, expedited DEA registrations and new financing opportunities under Schedule III, multiple federal proceedings involving MMJ In...

Dear Teva Pharmaceutical Stock Fans, Mark Your Calendars for September 14